[ACL] QoQ Quarter Result on 30-Jun-2021 [#Q4]

Stock
[ACL] Australian Clinical Labs Limited
Announcement Date
28-Jun-2021
Financial Year
2021
Quarter
30-Jun-2021 [#Q4]
Profit Trend
QoQ- 100.00%
YoY- -92.58%
Quarter Report
ACL's Result
ACL's Financial Summary
View:
Show?
Quarter Result
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
Revenue 228,802 538,001 269,001 328,798 164,399 317,904 158,952 27.51%
PBT 34,978 184,944 92,472 5,379 2,690 81,274 40,637 -9.52%
Tax 10,921 54,656 27,328 2,063 1,032 24,201 12,101 -6.61%
NP 24,015 130,214 65,107 3,300 1,650 57,073 28,537 -10.87%
Tax Rate -31.22% -29.55% -29.55% -38.35% -38.35% -29.78% -29.78% -
Total Cost 204,787 407,787 203,894 325,498 162,749 260,831 130,416 35.13%
Ratio Analysis
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
NP Margin 10.50 24.20 24.20 1.00 1.00 17.95 17.95 -30.07%
Per Share
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
EPS 0.12 0.65 0.32 0.02 0.01 0.28 0.20 -28.88%
EPS Diluted 0.12 0.65 0.32 0.02 0.01 0.28 0.20 -28.88%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.